AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
IMATINIB in Tunisia
7 products registered with DPM — 0 active, 7 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| IMATINIB NEAPOLIS Comprimé pelliculé / 100 mg | 9393142H | NEAPOLIS PHARMA | expired | 21 Sept 2020 |
| IMATINIB NEAPOLIS Comprimé pelliculé / 400 mg | 9393143H | NEAPOLIS PHARMA | expired | 21 Sept 2020 |
| IMATINIB NEAPOLIS Comprimé pelliculé / 100 mg | 9393141H | NEAPOLIS PHARMA | expired | 21 Sept 2020 |
| IMATINIB OPALIA Gélule / 400 mg | 9024072 | OPALIA PHARMA | expired | 18 Jul 2016 |
| IMATINIB OPALIA Gélule / 100 mg | 9024071 | OPALIA PHARMA | expired | 18 Jul 2016 |
| CEMIVIL Comprimé pelliculé sécable / 100 mg | 6653551H | HIKMA Pharmaceuticals | expired | 8 Jan 2014 |
| CEMIVIL Comprimé pelliculé sécable / 400 mg | 6653552H | HIKMA Pharmaceuticals | expired | 8 Jan 2014 |
IMATINIB — DPM Registration Details
DPM (Tunisia) has 7 registered products containing IMATINIB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track IMATINIB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.